Incidence and prevalence of iron deficiency anaemia
https://doi.org/10.21518/2079-701X-2018-13-78-81
Abstract
Iron deficiency anaemia (IDA) is one of the most common complications in pregnancy. It is known that IDA has an adverse effect on the condition of the mother, fetus and new-borns. The article presents modern views of the aetiology, pathogenesis, prevalence of iron deficiency anaemia, describes the clinical manifestations of this condition. The rational of treatment of IDA with modern ferric iron supplements is substantiated. It is shown that IDA therapy in pregnant and puerperal women with Maltofer is highly effective, leads to normalization of hemogram parameters, improvement of general condition, and reduction of obstetric and neonatal complications.
About the Authors
V. E. Zhorova
Sechenov First Moscow State Medical University of the Ministry of Health of Russia
Russian Federation
Russian Federation
E. G. Khilkevich
Kulakov National Medical Research Centre for Obstetrics, Gynaecology and Perinatology of the Ministry of Health of Russia
Russian Federation
Russian Federation
References
1. Serov VN, Burlev VA, Konovodova EN, et al. Clinical guidelines for diagnosis, prevention and treatment of iron deficiency in pregnant women and puerperas. Kulakov National Medical Research Centre for Obstetrics, Gynaecology and Perinatology of the Ministry of Health of Russia. 2012.
2. Tyutyunnik VL, Kan NE, Mikhailova OI, Dubrovina NV. Evaluation of the effectiveness of IDA treatment in pregnant women with Maltofer. Effektivnaya Farmakoterapiya, 2017, 26: 4-11.
3. Lovtsova L, Kuzin V, Osipova E. Clinical efficacy and safety of maltofer. Vrach, 2013, 8: 56-58.
4. Kolosova NG, Bayandina GN, Mashukova NG, Geppe NA. Iron metabolism and ways to correct its disorders. Trudny Patsient, 2011, 9 (8-9).
5. Radzinsky VE. Obstetric aggression. M.: StatusPraesens journal publisher, 2011: 191-201.
6. Tayupova IM. Vestnik SurGU. Meditsina, 2013, 3 (17): 39-42.
7. Vertkin AL, Godulyan OV, Gorodetsky VV, Skotnikov AS. Iron deficiency anemia and the choice of the drug for its correction. RMJ, 2010, 18 (5): 260-264.
8. Khovasova NO, Laryushkina ED. Iron deficiency anemia and latent iron deficiency in the practitioner practice: diagnosis and treatment. Ambulatorny Priem, 2015, 1 (1): 6-9.
9. Strutynsky AV. Iron deficiency anemia in the practitioner practice: diagnosis and treatment. Pharmateсa, 2012, 13. URL: http://www.pharmateca.ru/en/archive/article/8535 (accessed day is January 15, 2015).
10. Shurpyak SA. Hydroxidepolymaltose complex of ferric iron (maltofer) in the treatment and prevention of anemia during pregnancy, lactation and in the early postoperative period. Zdorovye Zhenshchiny, 2013, 6 (82): 58.
11. ACOG Practice Bulletin No. 95: anemia in pregnancy. Obstet Gynecol, 2008, 112(1): 201–208.
12. Van den Broek NR, Letsky EA. Etiology of anemia in pregnancy in south Malawi. Am J Clin Nutr, 2000, 72(1): 247S–256S.
13. Gorodetsky VV, Godulyan OV. Iron deficiency and iron deficiency anaemia: treatment and diagnosis. Guidelines. M.: Medpraktika-M, 2005.
Review
For citations:
Zhorova VE, Khilkevich EG. Incidence and prevalence of iron deficiency anaemia. Meditsinskiy sovet = Medical Council. 2018;(13):78-81. (In Russ.) https://doi.org/10.21518/2079-701X-2018-13-78-81
Views:
1789
Email this article 